Idexx Laboratories logo

Idexx Laboratories Income Statement

Revenue, expenses, and profitability over time

Idexx Laboratories generated $4.4B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $1.1B with a 24.63% net margin. Gross margin stands at 62.05% and operating margin at 31.63%. Diluted EPS is $13.59, which grew 0.3% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$41.7B
P/E Ratio38.08
ROE72.92%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$40.2M$67.4M$68.4M$70.2M$58.8M$77.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$216.1M$242.7M$294.0M$274.6M$248.2M$278.4M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$954.3M$998.4M$1.1B$1.1B$1.1B$1.1B